[
  {
    "ts": null,
    "headline": "Lexeo: Maintaining Buy Rating Based On FDA Accelerated Approval Feedback",
    "summary": "Lexeo Therapeutics received positive FDA feedback, enabling faster path to Accelerated Approval for LX2006 in FA cardiomyopathy. Click to read why LXEO is a Buy.",
    "url": "https://finnhub.io/api/news?id=7fe3e5185de539013a554348fe47dce6a0502b9b87e600b4f0e04eeb154656e4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759850542,
      "headline": "Lexeo: Maintaining Buy Rating Based On FDA Accelerated Approval Feedback",
      "id": 137002100,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2225720204/image_2225720204.jpg?io=getty-c-w1536",
      "related": "BIIB",
      "source": "SeekingAlpha",
      "summary": "Lexeo Therapeutics received positive FDA feedback, enabling faster path to Accelerated Approval for LX2006 in FA cardiomyopathy. Click to read why LXEO is a Buy.",
      "url": "https://finnhub.io/api/news?id=7fe3e5185de539013a554348fe47dce6a0502b9b87e600b4f0e04eeb154656e4"
    }
  },
  {
    "ts": null,
    "headline": "Neuromuscular Disease Therapeutics Market to Reach US$ 45.62 Billion by 2033 as Gene Therapies and RNA-based Treatments Redefine Patient Outcomes",
    "summary": "The Neuromuscular Disease Therapeutics Market is entering a period of accelerated growth, supported by breakthroughs in gene therapy, antisense oligonucleotides (ASOs), monoclonal antibodies, and small-molecule modulators. According to DataM Intelligence, the Neuromuscular Disease Therapeutics Market Size reached US$ 11.89 billion in 2023, rose to US$ 13.70 billion in 2024, and is projected to reach US$ 45.62 billion by 2033, growing at a CAGR of 14.4% during 2025–2033.",
    "url": "https://finnhub.io/api/news?id=9ca05e134f35b94c3ed25a19fb6a0ca3e0477aee5fb8d0a79f0c9e229d8b6e55",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759850400,
      "headline": "Neuromuscular Disease Therapeutics Market to Reach US$ 45.62 Billion by 2033 as Gene Therapies and RNA-based Treatments Redefine Patient Outcomes",
      "id": 136998885,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "The Neuromuscular Disease Therapeutics Market is entering a period of accelerated growth, supported by breakthroughs in gene therapy, antisense oligonucleotides (ASOs), monoclonal antibodies, and small-molecule modulators. According to DataM Intelligence, the Neuromuscular Disease Therapeutics Market Size reached US$ 11.89 billion in 2023, rose to US$ 13.70 billion in 2024, and is projected to reach US$ 45.62 billion by 2033, growing at a CAGR of 14.4% during 2025–2033.",
      "url": "https://finnhub.io/api/news?id=9ca05e134f35b94c3ed25a19fb6a0ca3e0477aee5fb8d0a79f0c9e229d8b6e55"
    }
  },
  {
    "ts": null,
    "headline": "Rare Disease Therapeutics Market to Surpass US$ 495.27 Billion by 2033 as Gene Therapy, RNA-based Drugs, and Biologics Transform Patient Care",
    "summary": "The Rare Disease Therapeutics Market is experiencing an unprecedented wave of innovation, driven by gene therapies, RNA-based treatments, enzyme replacement therapies (ERTs), and targeted biologics. According to DataM Intelligence, the Rare Disease Therapeutics Market Size reached US$ 135.88 billion in 2023, rose to US$ 154.64 billion in 2024, and is projected to reach US$ 495.27 billion by 2033, expanding at a CAGR of 13.8% during 2025–2033.",
    "url": "https://finnhub.io/api/news?id=ab39f8c16abd6bdfd8fb32b918f3a235397f60cf757e7ef69d08d758c0116eeb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759849200,
      "headline": "Rare Disease Therapeutics Market to Surpass US$ 495.27 Billion by 2033 as Gene Therapy, RNA-based Drugs, and Biologics Transform Patient Care",
      "id": 136999213,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "The Rare Disease Therapeutics Market is experiencing an unprecedented wave of innovation, driven by gene therapies, RNA-based treatments, enzyme replacement therapies (ERTs), and targeted biologics. According to DataM Intelligence, the Rare Disease Therapeutics Market Size reached US$ 135.88 billion in 2023, rose to US$ 154.64 billion in 2024, and is projected to reach US$ 495.27 billion by 2033, expanding at a CAGR of 13.8% during 2025–2033.",
      "url": "https://finnhub.io/api/news?id=ab39f8c16abd6bdfd8fb32b918f3a235397f60cf757e7ef69d08d758c0116eeb"
    }
  }
]